Featured Research

from universities, journals, and other organizations

First National And Evidence-based Guidelines For Brain Cancer Released

Date:
October 26, 2009
Source:
Henry Ford Health System
Summary:
The first national treatment guidelines for brain metastases, which account for nearly 500,000 new cancers annually in the United States, were recently released. The guidelines were developed by a 20-member panel in various specialties over the last year after reviewing the literature and reaching a consensus for different treatments.

The first national treatment guidelines for brain metastases, which account for nearly 500,000 new cancers annually in the United States, were recently released at the Congress of Neurological Surgeons in New Orleans.

Related Articles


The guidelines were developed by a 20-member panel in various specialties over the last year after reviewing the literature and reaching a consensus for different treatments. The panel was headed by neurosurgeon Steven Kalkanis, M.D., co-director of the Hermelin Brain Tumor Center at Henry Ford Hospital in Detroit.

"In the last 10 years, there has been an explosion of new treatments for brain metastases: surgical resection, stereotactic radiosurgery, whole brain radiation therapy, partial brain radiation, chemotherapy and various combinations of all the above," says Dr. Kalkanis.

"Because of the growth of these new technologies, there has been wide variation among physicians in how to treat patients. And there hasn't been a central source on which treatment regimens give the best results," adds Dr. Kalkanis.

"Our primary goal was to identify best treatment practices leading to the best outcomes for patients."

According to Dr. Kalkanis, there were 1.4 million individuals with cancer in 2008. Of those, 30 to 40 percent will develop brain metastasis, tumors which travel to the brain from other areas of the body, usually the breast or lung.

On the other hand, there are about 17,000 new cases annually of primary malignant brain tumors, cancers that originate in the brain.

Significantly, in cases where there was not enough data to suggest a guideline or recommendation for a particular treatment, the report lists all relevant ongoing clinical trials as well as needed future studies to inform the medical community and to foster support for continuing this important research.

The new brain metastases guidelines include:

  • a range of therapeutic options for treating brain metastases;
  • the existing evidence used to guide decision-making and its limitations;
  • the range of diversity in practice patterns and the various demographic factors that influence clinical decisions; and
  • the impact of expert reviews of published clinical evidence on practice regarding treatment options for brain metastases.

This strict evidenced-based protocol was endorsed by not only the Congress of Neurological Surgeons and American Association of Neurological Surgeons, but by the Joint Tumor Section and experts from a wide range of multidisciplinary fields including radiation oncology, medical oncology and neuro-oncology, as well as neurosurgery.

The guidelines will be published in a special issue of the Journal of Neuro-Oncology in December.


Story Source:

The above story is based on materials provided by Henry Ford Health System. Note: Materials may be edited for content and length.


Cite This Page:

Henry Ford Health System. "First National And Evidence-based Guidelines For Brain Cancer Released." ScienceDaily. ScienceDaily, 26 October 2009. <www.sciencedaily.com/releases/2009/10/091026152808.htm>.
Henry Ford Health System. (2009, October 26). First National And Evidence-based Guidelines For Brain Cancer Released. ScienceDaily. Retrieved October 31, 2014 from www.sciencedaily.com/releases/2009/10/091026152808.htm
Henry Ford Health System. "First National And Evidence-based Guidelines For Brain Cancer Released." ScienceDaily. www.sciencedaily.com/releases/2009/10/091026152808.htm (accessed October 31, 2014).

Share This



More Health & Medicine News

Friday, October 31, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Melafind: Spotting Melanoma Without a Biopsy

Melafind: Spotting Melanoma Without a Biopsy

Ivanhoe (Oct. 31, 2014) The MelaFind device is a pain-free way to check suspicious moles for melanoma, without the need for a biopsy. Video provided by Ivanhoe
Powered by NewsLook.com
Battling Multiple Myeloma

Battling Multiple Myeloma

Ivanhoe (Oct. 31, 2014) The answer isn’t always found in new drugs – repurposing an ‘old’ drug that could mean better multiple myeloma treatment, and hope. Video provided by Ivanhoe
Powered by NewsLook.com
Chronic Inflammation and Prostate Cancer

Chronic Inflammation and Prostate Cancer

Ivanhoe (Oct. 31, 2014) New information that is linking chronic inflammation in the prostate and prostate cancer, which may help doctors and patients prevent cancer in the future. Video provided by Ivanhoe
Powered by NewsLook.com
Sickle Cell: Stopping Kids’ Silent Strokes

Sickle Cell: Stopping Kids’ Silent Strokes

Ivanhoe (Oct. 31, 2014) Blood transfusions are proving crucial to young sickle cell patients by helping prevent strokes, even when there is no outward sign of brain injury. Video provided by Ivanhoe
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins